CI
BSX icon

CX Institutional’s Boston Scientific BSX Stock Holding History

CX Institutional’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$487K Buy
11,407
+1,942
+21% +$105K 0.01% 485
2026
Q1 		$594K Sell
9,465
-209
-2% -$16.7K 0.02% 427
2025
Q4 		$922K Buy
9,674
+595
+7% +$58.3K 0.03% 302
2025
Q3 		$886K Buy
9,079
+219
+2% +$22.7K 0.03% 319
2025
Q2 		$952K Buy
8,860
+165
+2% +$16.7K 0.03% 271
2025
Q1 		$877K Sell
8,695
-1,550
-15% -$156K 0.03% 285
2024
Q4 		$915K Buy
10,245
+1,451
+16% +$128K 0.04% 271
2024
Q3 		$737K Buy
8,794
+73
+0.8% +$5.75K 0.03% 322
2024
Q2 		$672K Sell
8,721
-46
-0.5% -$3.37K 0.03% 332
2024
Q1 		$600K Sell
8,767
-191
-2% -$12.3K 0.03% 342
2023
Q4 		$518K Sell
8,958
-191
-2% -$10.2K 0.03% 323
2023
Q3 		$483K Sell
9,149
-102
-1% -$5.35K 0.03% 331
2023
Q2 		$500K Sell
9,251
-111
-1% -$5.8K 0.03% 348
2023
Q1 		$466K Buy
9,362
+1,287
+16% +$60.7K 0.02% 354
2022
Q4 		$374K Buy
+8,075
New +$350K 0.02% 404
2022
Q3 		– Sell
-2,771
Closed -$103K – 542
2022
Q2 		$103K Buy
+2,771
New +$113K 0.01% 549
2021
Q4 		– Sell
-3,305
Closed -$143K – 401
2021
Q3 		$143K Buy
3,305
+275
+9% +$12.2K 0.01% 394
2021
Q2 		$130K Buy
3,030
+719
+31% +$30.2K 0.01% 394
2021
Q1 		$89K Buy
2,311
+413
+22% +$15.6K 0.01% 396
2020
Q4 		$68K Buy
1,898
+1,065
+128% +$38.4K 0.01% 400
2020
Q3 		$32K Buy
833
+382
+85% +$14.7K ﹤0.01% 456
2020
Q2 		$16K Buy
451
+66
+17% +$2.38K ﹤0.01% 483
2020
Q1 		$13K Sell
385
-134
-26% -$5.24K ﹤0.01% 422
2019
Q4 		$23K Hold
519
– – ﹤0.01% 337
2019
Q3 		$21K Buy
+519
New +$22K ﹤0.01% 364
2019
Q2 		– Sell
-210
Closed -$8K – 951
2019
Q1 		$8K Buy
+210
New +$8.02K ﹤0.01% 477

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
GI
Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return

CX Institutional's BSX Position: Q2 2026 in Review

CX Institutional increased its Boston Scientific (BSX) stake by 21% in Q2 2026, buying an estimated $105K and bringing the position to 11,407 shares worth $487K. The position accounts for 0.01% of the portfolio, ranked #485.

CX Institutional first reported a position in BSX in Q1 2019 and has held it in 26 quarters since. The position peaked at $952K in Q2 2025. 209 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • CX Institutional held 11,407 shares of Boston Scientific worth $487K as of Q2 2026.
  • CX Institutional bought 1,942 Boston Scientific shares in Q2 2026, an estimated $105K.
  • Boston Scientific made up 0.01% of CX Institutional's portfolio in Q2 2026, its #485 holding.
  • CX Institutional first reported a position in Boston Scientific in Q1 2019 and has held it in 26 quarters since.
  • CX Institutional's Boston Scientific position peaked at $952K in Q2 2025.
  • 209 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.